Loomis Sayles & Co. L P Sells 1,424,795 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Loomis Sayles & Co. L P reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 58.2% in the third quarter, HoldingsChannel reports. The firm owned 1,021,759 shares of the company’s stock after selling 1,424,795 shares during the quarter. Loomis Sayles & Co. L P’s holdings in Option Care Health were worth $31,981,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in OPCH. Dynamic Technology Lab Private Ltd bought a new stake in Option Care Health during the third quarter valued at approximately $701,000. Westfield Capital Management Co. LP raised its position in Option Care Health by 10.2% in the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock worth $203,204,000 after acquiring an additional 599,589 shares during the period. Icon Wealth Advisors LLC boosted its stake in shares of Option Care Health by 27.1% during the 3rd quarter. Icon Wealth Advisors LLC now owns 8,009 shares of the company’s stock worth $251,000 after acquiring an additional 1,708 shares during the last quarter. Citigroup Inc. increased its stake in shares of Option Care Health by 27.1% in the 3rd quarter. Citigroup Inc. now owns 516,680 shares of the company’s stock worth $16,172,000 after purchasing an additional 110,012 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Option Care Health by 2.6% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 2,518,923 shares of the company’s stock worth $78,842,000 after purchasing an additional 63,955 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were purchased at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is owned by company insiders.

Option Care Health Stock Up 1.2 %

NASDAQ OPCH opened at $23.40 on Tuesday. The stock has a 50 day moving average price of $27.45 and a 200-day moving average price of $29.05. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63. The company has a market capitalization of $3.98 billion, a P/E ratio of 19.66, a P/E/G ratio of 2.39 and a beta of 1.32. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the company. Truist Financial reduced their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Barrington Research dropped their price target on shares of Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $43.00 to $29.00 in a research report on Wednesday, October 30th. Finally, Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. Three analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $30.83.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.